Project Company Due Diligence The problem A German Biotech company ran into financial problems primary clinical data of the most advanced product ... Project Company Due Diligence - ACCELLA ADVISORS GmbH 26.05.2016 00:28:14 http://accella-advisors.com/reference4.html

Project Business Development The problem A German biotech company wanted to enhance its pipeline through in-licensing of products with strategic fit ... Project Business Development - ACCELLA ADVISORS GmbH ... 26.05.2016 00:28:14 http://accella-advisors.com/reference2.html

Project Financing The problem A German biotech company needed support in their fundraising for a first institutional round. The solution Project Financing - ACCELLA ADVISORS GmbH 26.05.2016 00:28:14 http://accella-advisors.com/reference1.html

Project Market Entry Study The problem A Japanese pharmaceutical company wanted to evaluate the market opportunity for a cardiovascular product in ... Project Market Entry Study - ACCELLA ADVISORS GmbH ... 26.05.2016 00:28:13 http://accella-advisors.com/reference3.html

Services for Investors. Most venture funds have a company portfolio with a wide range of technologies. Considering the fast development of new technologies ... ACCELLA ADVISORS GmbH Services for Investors 26.05.2016 00:28:13 http://accella-advisors.com/service2.html

Services for Non- European Pharma and Biotech Companies. Midsize pharma and biotech companies US Japan India often lack market knowledge for growing ... ACCELLA ADVISORS GmbH Services for Non- European Pharma ... 26.05.2016 00:28:13 http://accella-advisors.com/service3.html

Project Turnaround Management The problem An Austrian biotech company with an innovative mechanism of action had problems rounding out the syndicate ... Project Turnaround Management - ACCELLA ADVISORS GmbH ... 26.05.2016 00:28:13 http://accella-advisors.com/reference5.html

ACCELLA ADVISORS GmbH Health Advisory Services for Biotech and Pharma Companies and Venture Funds ACCELLA ADVISORS GmbH Imprint 26.05.2016 00:28:13 http://accella-advisors.com/imprint.html